Related Experiment Video
Updated: Dec 5, 2025

Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Duchenne Muscular Dystrophy Newborn Screening, a Case Study for Examining Ethical and Legal Issues for Pilots for
Michele A Lloyd-Puryear1, Thomas O Crawford2, Amy Brower3
1Parent Project Muscular Dystrophy, 401 Hackensack Avenue, 9th Floor, Hackensack, NJ 07601, USA.
Insights
Newborn screening for Duchenne muscular dystrophy (DMD) can improve patient outcomes. This initiative explored the ethical and legal considerations for implementing DMD newborn screening programs.
Area of Science:
- Genetics
- Pediatrics
- Public Health
Background:
- Duchenne muscular dystrophy (DMD) is a severe pediatric genetic disease affecting 1 in 5000 males.
- Early diagnosis and intervention significantly extend lifespan for DMD patients.
- The therapeutic landscape for DMD is evolving, necessitating proactive screening strategies.
Purpose of the Study:
- To address the bioethical and legal issues surrounding newborn screening (NBS) for Duchenne muscular dystrophy.
- To develop recommendations for implementing DMD NBS programs.
- To facilitate consensus on key ethical and legal challenges related to DMD NBS.
Main Methods:
- Convened a Bioethics and Legal Issues Workgroup under Parent Project Muscular Dystrophy's NBS initiative.
- Conducted year-long conference calls to discuss identified issues.
- Focused discussions exclusively on Duchenne muscular dystrophy newborn screening.
Main Results:
- Identified and analyzed key bioethical and legal issues pertinent to DMD NBS.
- Achieved consensus on various complex issues related to screening.
- Generated findings and recommendations for future action.
Conclusions:
- Newborn screening for Duchenne muscular dystrophy presents significant bioethical and legal considerations.
- Proactive planning and consensus-building are crucial for successful implementation of DMD NBS.
- The workgroup's findings provide a foundation for establishing ethical and legal frameworks for DMD NBS.
Abstract:
Duchenne muscular dystrophy (DMD/Duchenne) is one of the ten most severe and common pediatric genetic diseases and affects an estimated 1 in every 5000 male births. While Duchenne is a 100% fatal disease, the clinical community has demonstrated that immediate identification and early clinical interventions can add years, even decades to an individual's life span. In anticipation of the changing therapeutic landscape for the Duchenne community, Parent Project Muscular Dystrophy established a newborn screening (NBS) initiative. This initiative included a Bioethics and Legal Issues Workgroup to consider the bioethics and legal issues of NBS for Duchenne. The workgroup's discussion focused only on Duchenne NBS and met through conference calls over a one-year period of time seeking consensus on various identified issues. This article reports on the findings and recommendations from that workgroup.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...